Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00497
|
|||||
| Drug Name |
Desloratadine
|
|||||
| Synonyms |
8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; Aerius; Aerius (TN); Allex; Azomyr; Claramax; Claramax (TN); Clarinex; Clarinex (TN); Clarinex RediTabs; Denosin; Desalex; Descarboethoxyloratadine; Descarboethoxyoratidine; Desloratadine (USAN/INN); Desloratadine [USAN]; Desloratidine; Essex brand of desloratadine; NeoClarityn (TN); Neoclarityn; Opulis; Sch 34117; Sch-34117; Schering brand of desloratadine; Schering-Plough brand of desloratadine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Allergic rhinitis [ICD11: CA08.0] | Approved | [1] | |||
| Therapeutic Class |
Antiallergic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H19ClN2
|
|||||
| Canonical SMILES |
C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
|
|||||
| InChI |
InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2
|
|||||
| InChIKey |
JAUOIFJMECXRGI-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 100643-71-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 310.8 | Topological Polar Surface Area | 24.9 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
4.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10240975
, 103341726
, 103966640
, 104420034
, 104829344
, 11528904
, 117782347
, 12013632
, 124659138
, 125325449
, 125336452
, 126584136
, 126630167
, 126656876
, 126670272
, 126728408
, 128248166
, 134337643
, 134358654
, 135078453
, 135916143
, 137001891
, 142370109
, 144076154
, 14742700
, 14874264
, 17397787
, 25623633
, 26719697
, 26754458
, 29215232
, 29215233
, 29304216
, 4480883
, 46386563
, 46507996
, 49830094
, 50086379
, 515991
, 53790902
, 57340751
, 75986670
, 85209723
, 85483828
, 87561219
, 92307949
, 92308612
, 92309042
, 92712182
, 93619677
|
|||||
| ChEBI ID |
CHEBI:291342
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Desloratadine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists. Drug Metab Dispos. 2003 Mar;31(3):312-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.